期刊文献+

Specific probiotics alleviate allergic rhinitis during the birch pollen season 被引量:19

Specific probiotics alleviate allergic rhinitis during the birch pollen season
下载PDF
导出
摘要 AIM: To investigate whether birch pollen allergy symptoms are linked with gut microbiota changes and whether probiotics have an effect on these. METHODS: Forty seven children with confirmed birch pollen allergy were randomized to receive either a probiotic combination of Lactobacillus acidophilus (L. acidophilus) NCFM^TM (ATCC 700396) and Bifidobacterium lactis (B. lactis) BI-04 (ATCC SD5219) or placebo in a double-blind manner for 4 mo, starting prior to onset of the birch pollen season. Symptoms were recorded in a diary. Blood samples were taken for analysis of cytokines and eosinophils. Fecal samples were analysed for microbiota components, calprotectin and IgA. Nasal swabs were taken for analysis of eosinophils.RESULTS: The pollen season induced a reduction in Bifldobacterium , Clostridium and Bacteroides which could not be prevented by the probiotic intervention. During the intervention, significantly higher numbers ofB. lactis 11.2 × 10^7 ± 4.2 ×10^7 vs 0.1 × 10^7 ± 0.1 × 10^7 bacteria/g feces (P 〈 0.0001) and L. acidophilus NCFMTM 3.5 × 10^6 ± 1.3 × 10^6 vs 0.2 × 10^6 ±0.1 × 10^6 bacteria/g feces (P 〈 0.0001) were observed in the probiotic group compared to the placebo group.During May, there was a tendency for fewer subjects, (76.2% vs 95.2%, P = 0.078) to report runny nose, while during June, fewer subjects, 11.1% vs 33.3%, reported nasal blocking in the probiotics group (P = 0.101). Concomitantly, fewer subjects in the probiotic group had infiltration of eosinophils in the nasal mucosa compared to the placebo group, 57.1% vs 95% (P = 0.013). Eye symptoms tended to be slightly more frequent in the probiotic group, 12.5 d [interquartile range (IQR) 6-18] vs 7.5 d (IQR 0-11.5) (P = 0.066) during May. Fecal IgA was increased in the placebo group during the pollen season; this increase was prevented by the probiotics (P = 0.028). CONCLUSION: Birch pollen allergy was shown to be associated with changes in fecal microbiota composition. The specific combination of probiotics used was shown to prevent the pollen-induced infiltration of eosinophils into the nasal mucosa, and indicated a trend for reduced nasal symptoms. AIM:To investigate whether birch pollen allergy symptoms are linked with gut microbiota changes and whether probiotics have an effect on these.METHODS:Forty seven children with confirmed birch pollen allergy were randomized to receive either a probiotic combination of Lactobacillus acidophilus (L.acidophilus) NCFMTM (ATCC 700396) and Bifidobacterium lactis (B.lactis) Bl-04 (ATCC SD5219) or placebo in a double-blind manner for 4 mo,starting prior to onset of the birch pollen season.Symptoms were recorded in a diary.Blood samples were taken for analysis of cytokines and eosinophils.Fecal samples were analysed for microbiota components,calprotectin and IgA.Nasal swabs were taken for analysis of eosinophils.RESULTS:The pollen season induced a reduction in Bifidobacterium,Clostridium and Bacteroides which could not be prevented by the probiotic intervention.During the intervention,significantly higher numbers of B.lactis 11.2×107 ± 4.2×107 vs 0.1×107 ± 0.1×107 bacteria/g feces (P<0.0001) and L.acidophilus NCFMTM 3.5×106 ± 1.3×106 vs 0.2×106 ± 0.1×106 bacteria/g feces (P<0.0001) were observed in the probiotic group compared to the placebo group.During May,there was a tendency for fewer subjects,(76.2% vs 95.2%,P=0.078) to report runny nose,while during June,fewer subjects,11.1% vs 33.3%,reported nasal blocking in the probiotics group (P =0.101).Concomitantly,fewer subjects in the probiotic group had infiltration of eosinophils in the nasal mucosa compared to the placebo group,57.1% vs 95% (P=0.013).Eye symptoms tended to be slightly more frequent in the probiotic group,12.5 d [interquartile range (IQR) 6-18] vs 7.5 d (IQR 0-11.5) (P=0.066) during May.Fecal IgA was increased in the placebo group during the pollen season;this increase was prevented by the probiotics (P=0.028).CONCLUSION:Birch pollen allergy was shown to be associated with changes in fecal microbiota composition.The specific combination of probiotics used was shown to prevent the pollen-induced infiltration of eosinophils into the nasal mucosa,and indicated a trend for reduced nasal symptoms.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第26期3261-3268,共8页 世界胃肠病学杂志(英文版)
基金 Supported by Danisco (partial)
  • 相关文献

参考文献29

  • 1Asher MI,Montefort S,Bjorkstén B,Lai CK,Strachan DP,Weiland SK,Williams H.Worldwide time trends in the prevalence of symptoms of asthma,allergic rhinoconjunctivitis,and eczema in childhood:ISAAC Phases One and Three repeat multicountry cross-sectional surveys.Lancet 2006; 368:733-743.
  • 2Braunstahl GJ,Overbeek SE,Kleinjan A,Prins JB,Hoogsteden HC,Fokkens WJ.Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways.J Allergy Clin Immunol 2001; 107:469-476.
  • 3Braunstahl GJ,Overbeek SE,Fokkens WJ,Kleinjan A,McEuen AR,Walls AF,Hoogsteden HC,Prins JB.Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa.Am J Respir Crit Care Med 2001; 164:858-865.
  • 4Settipane RJ,Hagy GW,Settipane GA.Long-term risk factors for developing asthma and allergic rhinitis:a 23-year follow-up study of college students.Allergy Proc 1994; 15:21-25.
  • 5Hughes JL,Lackie PM,Wilson SJ,Church MK,McGill JI.Reduced structural proteins in the conjunctival epithelium in allergic eye disease.Allergy 2006; 61:1268-1274.
  • 6FAO/WHO.Guidelines for the evaluation of probiotics in food.Available from:URL:http://www.who.int/foodsafety/publications/fs_management/probiotics2/en/.
  • 7Kalliom.ki M,Salminen S,Poussa T,Isolauri E.Probiotics during the first 7 years of life:a cumulative risk reduction of eczema in a randomized,placebo-controlled trial.J Allergy Clin Immunol 2007; 119:1019-1021.
  • 8Kalliom.ki M,Salminen S,Poussa T,Arvilommi H,Isolauri E.Probiotics and prevention of atopic disease:4-year follow-up of a randomised placebo-controlled trial.Lancet 2003; 361:1869-1871.
  • 9Kalliom.ki M,Salminen S,Arvilommi H,Kero P,Koskinen P,Isolauri E.Probiotics in primary prevention of atopic disease:a randomised placebo-controlled trial.Lancet 2001;357:1076-1079.
  • 10Isolauri E,Arvola T,Sütas Y,Moilanen E,Salminen S.Probiotics in the management of atopic eczema.Clin ExpAllergy 2000; 30:1604-1610.

同被引文献124

引证文献19

二级引证文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部